Weight-loss treatment is on the verge of a dramatic shift – again
6 hours ago
- #weight-loss
- #GLP-1
- #healthcare
- Charles Barkley highlights the popularity of the new GLP-1 weight-loss pill in a Ro commercial.
- The Wegovy pill, approved by the FDA, is now used by about 400,000 Americans.
- A second weight-loss pill is under FDA review, with more monthly and powerful drugs in trials.
- Retatrutide, a 'Triple G' drug by Eli Lilly, shows record weight loss (up to 29% body weight).
- Novo Nordisk's higher-dose Wegovy approved, showing 21% weight loss, competing with Lilly's Zepbound.
- New weight-loss pills like orforglipron offer convenience, with fewer restrictions than Wegovy.
- Costs for weight-loss drugs have dropped, but insurance coverage remains inconsistent.
- Concerns arise over inappropriate use of powerful weight-loss drugs for minor weight loss.
- Supply issues for GLP-1 drugs have improved, including pill versions changing treatment options.